skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or hit Enter to replace search target
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Venom allergen immunotherapy
Golden, David B. K.
Allergy and asthma proceedings, 2022-07, Vol.43 (4), p.339-343
[Periódico revisado por pares]
United States: OceanSide Publications, Inc
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Venom allergen immunotherapy
Autor:
Golden, David B. K.
Assuntos:
Allergens
;
Allergic reactions
;
Anaphylaxis
;
Anaphylaxis - chemically induced
;
Anaphylaxis - prevention & control
;
Animals
;
Arthropod Venoms - therapeutic use
;
Bee Venoms
;
Desensitization, Immunologic - adverse effects
;
Humans
;
Hymenoptera
;
Hypersensitivity
;
Immunoglobulin E
;
Immunotherapy
;
Insect Bites and Stings - therapy
;
Insects
;
Patients
;
Risk analysis
;
Risk factors
;
Rubber products
;
Skin tests
;
Stings
;
Tryptase
;
Venom
;
Wasp Venoms
É parte de:
Allergy and asthma proceedings, 2022-07, Vol.43 (4), p.339-343
Notas:
1088-5412(20220701)43:4L.339;1-
(RF) Otorhinolaryngology
Descrição:
Venom immunotherapy (VIT) with Hymenoptera venom extracts is highly effective in preventing large local, systemic allergic, and anaphylactic reactions to insect stings. VIT is not required for patients with cutaneous systemic or large local allergic reactions to stings because it is uncommon for reactions to become more severe. The clinical history, with confirmatory skin or serum tests for venom IgE, can clarify the risk for future anaphylaxis and the need for VIT. For initial treatment, rush regimens are recommended because they have the same or less risk of systemic reactions than slower traditional regimens. VIT is relatively safe with a low incidence of systemic reactions. Injection-site reactions can be bothersome but do not predict systemic reactions to venom injections. Patients who need VIT should be screened for baseline serum tryptase and possible underlying mast cell disorders. VIT can be discontinued after five years in most patients, but those with known high-risk factors should continue VIT indefinitely.
Editor:
United States: OceanSide Publications, Inc
Idioma:
Inglês
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript
Página Inicial
RSS
Feed
Políticas
Fale Conosco
Logos de Redes Sociais: 
Logos de Redes Sociais: